Catalyst
Slingshot members are tracking this event:
Progenics (PGNX) Phase 2 Results Evaluating SPECT/CT Agent 1404 Published in Journal of Nuclear Medicine
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PGNX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 24, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2, Spect/ct, 1404, Journal Of Nuclear Medicine
